Double-Blind Study — Glossary | Creatine.my

Written by Creatine.my Editorial Team · · 3 min read
3 min read

What is a Double-Blind Study?

A double-blind study (also called a double-blind randomized controlled trial, or double-blind RCT) is a research design where neither the participants nor the researchers know who is receiving the active treatment and who is receiving a placebo.

This “blinding” eliminates conscious and unconscious bias from both parties, producing the most reliable evidence about a treatment’s effectiveness.

The double-blind RCT is widely considered the gold standard of clinical research methodology.

When multiple double-blind RCTs are combined in a meta-analysis, the evidence reaches the highest level of scientific certainty.

How It Works

In a typical double-blind creatine study:

  1. Randomization — Participants are randomly assigned to either the creatine group or the placebo group
  2. Blinding — Both groups receive identical-looking supplements; neither participants nor researchers know which is which
  3. Intervention — Both groups follow the same protocol (dosage, timing, training program)
  4. Measurement — Outcomes (strength, muscle mass, performance) are measured objectively
  5. Unblinding — After data collection, the code is revealed and groups are compared

The placebo group typically receives an inert substance (like maltodextrin) that matches the creatine supplement in appearance, taste, and texture.

Why It Matters for Creatine Evidence

Creatine’s reputation as the most evidence-backed supplement is built largely on double-blind RCTs. Key points:

  • Over 500 peer-reviewed studies have examined creatine, many using double-blind designs
  • Consistent findings across studies, populations, and research groups
  • Results are reproducible — different labs in different countries find similar outcomes
  • The International Society of Sports Nutrition bases its position statement on this body of double-blind evidence

This level of evidence far exceeds most other dietary supplements, many of which rely primarily on observational data, animal studies, or uncontrolled trials.

Relevance to Creatine Supplementation

When evaluating any supplement claim, ask: “Is this supported by double-blind, placebo-controlled research?” For creatine, the answer is a resounding yes across multiple outcome measures including strength, power, muscle mass, cognitive function, and recovery.

  • Meta-Analysis — Combining multiple double-blind studies for stronger conclusions
  • Ergogenic Aid — The category of performance enhancers creatine belongs to
  • Bioavailability — A property often measured in double-blind studies

Sources & References

Full citations available in our Research Library.

Frequently Asked Questions

What makes a double-blind study the gold standard?

In a double-blind study, neither participants nor researchers know who receives the treatment and who receives the placebo. This eliminates bias from both sides: participants cannot perform differently based on expectations, and researchers cannot unconsciously influence results. Combined with randomization, this design provides the most reliable evidence of a supplement's effects.

How many double-blind studies support creatine?

Creatine has been evaluated in over 500 peer-reviewed studies, many of which use double-blind, placebo-controlled designs. This extensive evidence base is why organisations like the ISSN, ACSM, and IOC have issued positive position statements on creatine supplementation. Few supplements have this level of rigorous scientific support.

Can I trust studies that are not double-blind?

Non-blinded studies can still provide useful information, but they are more susceptible to bias. Open-label studies, case reports, and observational research have value but should be weighted less heavily than double-blind RCTs when evaluating supplement efficacy. For creatine, the evidence from double-blind studies is overwhelmingly positive.

Reviewed by T. Dinaiz, BSc (Molecular Biology), MSc (Biotechnology)

Reviewed against peer-reviewed research · Our editorial policy